Review Articles
Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora’s box?
A. Liew, J. H. McDermott, F. Barry T. O’Brien
pages 353–366
The effect of thiazolidinediones on adiponectin serum level: a meta-analysis
N. Riera-Guardia D. Rothenbacher
pages 367–375
Original Articles
Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes*
J. Rosenstock, S. Sankoh J. F. List
pages 376–386
Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial*
M. Davies, F. Lavalle-González, F. Storms R. Gomis (AT.LANTUS Study Group)
pages 387–399
Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise
H. Yokoyama, K. Mori, M. Emoto, T. Araki, M. Teramura, K. Mochizuki, T. Tashiro, K. Motozuka, Y. Inoue Y. Nishizawa
pages 400–407
Beta cells in type 2 diabetes a crucial contribution to pathogenesis
Kathrin Maedler
pages 408–420
Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up
M. Alvarsson, G. Sundkvist, I. Lager, K. Berntorp, E. Fernqvist-Forbes, L. Steen, T. Örn, M. A. Holberg, N. Kirksæther V. Grill
pages 421–429
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study
E. Mannucci, M. Monami, B. Cresci, L. Pala, G. Bardini, M. G. Petracca, I. Dicembrini, A. Pasqua, E. Buiatti C. M. Rotella
pages 430–435
Correspondence
Letter to the Editor
Response to Pokharna and Kanna: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes
A. Garber
pages 436–437
News and Views
News and Views
Iskandar Idris
pages 438–440
This week's Diabetes Bulletin...
...
No comments:
Post a Comment